Stockholm - Delayed Quote SEK
Biosergen AB (BIOSGN.ST)
0.5380
+0.0080
+(1.51%)
At close: May 28 at 12:33:58 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
52,850
7,201
33,790
29,486
Total Liabilities Net Minority Interest
3,709
5,085
10,996
9,253
Total Equity Gross Minority Interest
49,141
2,116
22,794
20,233
Total Capitalization
49,141
2,116
22,794
20,233
Common Stock Equity
49,141
2,116
22,794
20,233
Net Tangible Assets
49,141
2,116
22,794
20,233
Working Capital
48,208
2,116
22,793
20,232
Invested Capital
--
2,116
22,794
20,233
Tangible Book Value
49,141
2,116
22,794
20,233
Share Issued
234,823.2120
85,727.9410
71,760.3630
53,489.8010
Ordinary Shares Number
234,823.2120
85,727.9410
71,760.3630
53,489.8010
12/31/2021 - 6/24/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIDDS.ST LIDDS AB (publ)
0.0320
-35.48%
CANTA.ST Cantargia AB (publ)
1.4740
-1.07%
KAN.ST Kancera AB (publ)
1.0120
+1.30%
CMOTEC-B.ST Scandinavian ChemoTech AB (publ)
1.9650
-1.75%
QUIA.ST Quia Pharma AB (publ)
0.0063
-1.56%
APTA.ST Aptahem AB (publ)
1.1500
+0.88%
COMBI.ST CombiGene AB (publ)
2.5000
+1.21%
ATORX.ST Alligator Bioscience AB (publ)
4.1000
+0.06%
SPAGO.ST Spago Nanomedical AB (publ)
0.2040
-15.00%
NANECH.ST NanoEcho AB
0.1024
+0.59%